CARMEL,
Ind., March 21, 2024 /PRNewswire/ -- Syra
Health Corp. (NASDAQ: SYRA), a healthcare technology company
with a mission to improve healthcare by providing innovative
services and technology solutions, announced today its been awarded
a contract from the Sedgwick County Health Department in
Kansas to train first responders
and community members on substance use disorder and overdose
prevention. The four-year contract underscores Syra Health's
commitment to healthcare education and training.
Syra Health's comprehensive educational training program is
designed for the public safety of the community. The overall
objective of the training is to equip healthcare professionals,
community leaders, and individuals with the knowledge and skills
necessary to effectively prevent, identify, and manage substance
use disorder, using evidence-based practices and innovative
approaches. Specifically, Syra Health will provide ongoing,
culturally relevant, educational trainings on stigma reduction
surrounding substance use disorder, education on substance use
disorder itself, and substance overdose prevention strategies.
According to a 2022 National Survey on Drug Use and Health,
approximately 17.3% of people aged 12 or
older in the United
States had a substance use disorder within the
past year. This includes 29.5 million individuals
with an alcohol use disorder, 27.2 million with
a drug use disorder, and 8.0
million people who experienced both an alcohol and drug
use disorder. Among young adults aged 18 to 25,
nearly 48.8% had either a substance use disorder
or a mental illness during the same period.
Dr. Deepika Vuppalanchi, CEO,
Syra Health, emphasized the
importance of this collaboration, "This contract underscores our
shared commitment to addressing this critical public health issue.
It's essential to understand the prevalence of substance use
disorders in the United States and
the strategies that are helping improve health for those on the
front line and those in community with one another."
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such
as behavioral and mental health, digital health,
and population health, by providing innovative services and
technology solutions. Syra Health's products and services are
centered on prevention, improved access, and affordable care. Syra
Health supplies its solutions to payers, providers, life sciences
organizations, academic institutions, and government. For more
information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations,
plans, and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
"forward-looking statements." These statements include, but are not
limited to, statements relating to the expected use of proceeds,
the Company's operations and business strategy and the Company's
expected financial results. The words "anticipate," "believe,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will,"
"would" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. The forward-looking
statements contained in this press release are based on
management's current expectations and are subject to substantial
risks, uncertainty and changes in circumstances. Investors should
read the risk factors set forth in our registration statement on
Form S-1 and other periodic reports filed with the Securities and
Exchange Commission. Any forward-looking statements contained in
this press release speak only as of the date hereof, and, except as
required by federal securities laws, the Company specifically
disclaims any obligation to update any forward-looking statements,
whether as a result of new information, future events, or
otherwise.
For more information, please contact:
For Media Inquiries:
Christine
Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben
Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-to-deliver-substance-use-disorder-and-overdose-prevention-training-in-kansas-302095879.html
SOURCE Syra Health
